Mark Goldin

InstitutionFeinstein Institutes for Medical Research
AddressManhasset
New York
United States
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 6 Covid-19 publications, with a maximum of 2 publications in June 2021
    All Publications
    Bar chart showing 15 publications over 7 distinct years, with a maximum of 6 publications in 2021
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Spyropoulos AC, Giannis D, Goldin M. Vascular thromboembolic events following COVID-19 hospital discharge: Incidence and risk factors. Res Pract Thromb Haemost. 2021 Jul; 5(5):e12547. PMID: 34263101.
      Citations: 1     
    2. Goldin M, Lin SK, Kohn N, Qiu M, Cohen SL, Barish MA, Gianos E, Diaz A, Richardson S, Giannis D, Chatterjee S, Coppa K, Hirsch JS, Ngu S, Firoozan S, McGinn T, Spyropoulos AC. External validation of the IMPROVE-DD risk assessment model for venous thromboembolism among inpatients with COVID-19. J Thromb Thrombolysis. 2021 Nov; 52(4):1032-1035. PMID: 34146235.
      Citations: 2     Fields:    Translation:Humans
    3. Giannis D, Allen SL, Tsang J, Flint S, Pinhasov T, Williams S, Tan G, Thakur R, Leung C, Snyder M, Bhatia C, Garrett D, Cotte C, Isaacs S, Gugerty E, Davidson A, Marder GS, Schnitzer A, Goldberg B, McGinn T, Davidson KW, Barish MA, Qiu M, Zhang M, Goldin M, Matsagkas M, Arnaoutoglou E, Spyropoulos AC. Postdischarge thromboembolic outcomes and mortality of hospitalized patients with COVID-19: the CORE-19 registry. Blood. 2021 05 20; 137(20):2838-2847. PMID: 33824972.
      Citations: 11     Fields:    Translation:Humans
    4. Goldin M, Giannis D, Diab W, Wang J, Khanijo S, Sharifova G, Cohen M, Lund JM, Mignatti A, Gianos E, Tafur A, Lewis PA, Cohoon K, Kittelson JM, Lesser ML, Sison CP, Rahman H, Ochani K, Hiatt WR, Dale RA, Anderson VE, Bonaca M, Halperin JL, Weitz JI, Spyropoulos AC. Treatment-Dose LMWH versus Prophylactic/Intermediate Dose Heparins in High-Risk COVID-19 Inpatients: Rationale and Design of the HEP-COVID Trial. Thromb Haemost. 2021 Dec; 121(12):1684-1695. PMID: 33823560.
      Citations: 2     Fields:    Translation:HumansCTClinical Trials
    5. Giannis D, Barish MA, Goldin M, Cohen SL, Kohn N, Gianos E, Chatterjee S, Lesser M, Coppa K, Hirsch JS, McGinn T, Spyropoulos AC. Incidence of Venous Thromboembolism and Mortality in Patients with Initial Presentation of COVID-19. J Thromb Thrombolysis. 2021 May; 51(4):897-901. PMID: 33665766.
      Citations: 2     Fields:    Translation:Humans
    6. Spyropoulos AC, Cohen SL, Gianos E, Kohn N, Giannis D, Chatterjee S, Goldin M, Lesser M, Coppa K, Hirsch JS, McGinn T, Barish MA. Validation of the IMPROVE-DD risk assessment model for venous thromboembolism among hospitalized patients with COVID-19. Res Pract Thromb Haemost. 2021 Feb; 5(2):296-300. PMID: 33733028.
      Citations: 4